Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients. [electronic resource]
Producer: 19980514Description: 83-9 p. digitalISSN:- 0960-8931
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- Female
- Humans
- Immunophenotyping
- Injections, Intravenous
- Lymphocytes, Tumor-Infiltrating -- pathology
- Male
- Melanoma -- immunology
- Middle Aged
- Skin Neoplasms -- immunology
- Survival Rate
- Thymopentin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.